Menard Financial Group’s ResMed RMD Stock Holding History

Menard Financial Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-428	Closed	-$97.9K	–	263
2024 Q4	$97.9K	Buy	+428	New	+$103K	0.06%	143

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Menard Financial Group's RMD Position: Q1 2025 in Review

Menard Financial Group sold out of ResMed (RMD) in Q1 2025, closing a stake of 428 shares — an estimated $97.9K sold.

Menard Financial Group first reported a position in RMD in Q4 2024 and held it in 1 quarter. The position peaked at $97.9K in Q4 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

Menard Financial Group reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
Menard Financial Group sold 428 ResMed shares in Q1 2025, an estimated $97.9K.
Menard Financial Group first reported a position in ResMed in Q4 2024 and held it in 1 quarter.
Menard Financial Group's ResMed position peaked at $97.9K in Q4 2024.
885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Menard Financial Group's 13F filing for Q1 2025, filed 8 May 2025.